前交叉韧带重建联合与不联合外侧关节外肌腱固定至少2年随访:随机对照试验的荟萃分析与系统综述
该荟萃分析与系统综述纳入7项随机对照试验,共517例LEAT组和589例非LEAT组患者,比较ACLR联合LEAT与单纯ACLR的临床结局和并发症。结果显示LEAT组残余轴移试验阳性风险更低、IKDC和Lysholm评分更优、移植肌腱再断裂率低3倍。结论支持LEAT在改善前外侧稳定性和减少再断裂方面的疗效,但评分差异可能无临床意义。
要点
- IKDC和Lysholm评分虽统计学更优,但差异可能无临床意义。
核心结论
- 高质量证据支持LEAT在初次ACLR中改善膝关节前外侧稳定性并减少移植肌腱再断裂。
- LEAT应考虑用于具有高风险因素的患者。
- 尽管LEAT组Lysholm和IKDC评分统计学更优,但这些差异不太可能具有临床意义。
研究设计与样本
- 研究设计为荟萃分析与系统综述,证据等级1级。
- 于2020年9月9日按照PRISMA指南进行多数据库检索(Cochrane、EMBASE、OVID Medline、PubMed和Web of Science)。
- 纳入7项随机对照试验,共517例LEAT组和589例非LEAT组患者。
- ACLR和LEAT仅使用自体移植物,LEAT技术和自体移植物固定方法多样。
- 数据采用逆方差统计模型进行分析。
关键数值与推荐
- 纳入标准为直接比较ACLR联合LEAT与单纯ACLR、至少2年随访的随机对照试验。
临床怎么用
- 在初次ACLR中可考虑联合LEAT以改善前外侧稳定性并降低再断裂风险。
- LEAT应优先考虑用于具有高风险因素的患者。
- IKDC和Lysholm评分的统计学改善需结合临床意义审慎解读。
局限性
- LEAT技术和自体移植物固定方法存在多样性。
- IKDC和Lysholm评分的组间差异虽统计学显著但不太可能具有临床意义。
- 未来研究应致力于识别最可能从ACLR联合LEAT中获益的患者人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lateral extra-articular tenodesis (LEAT) aims to improve anterolateral stability of the injured knee during anterior cruciate ligament reconstruction (ACLR) surgery. Inconclusive evidence surrounding the efficacy and safety of LEAT has propelled clinical interest and ongoing discussions. PURPOSE: To establish level 1 evidence by assessing randomized controlled trials (RCTs) with minimum 2-year follow-up that directly compared ACLR with LEAT (LEAT group) and ACLR alone (non-LEAT group) in terms of clinical outcomes and complications. STUDY DESIGN: Meta-analysis and systematic review; Level of evidence, 1. METHODS: Meta-analysis was performed with a multidatabase search (Cochrane, EMBASE, OVID Medline, PubMed, and Web of Science) according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines on September 9, 2020. Data from published RCTs meeting inclusion criteria were extracted and analyzed with an inverse variance statistical model. RESULTS: A total of 7 RCTs were included, consisting of 517 LEAT and 589 non-LEAT patients. Only autografts were used for ACLR and LEAT. A variety of LEAT techniques and autograft fixation methods were used. We found improved stability (residual positive pivot shift: risk ratio [RR], 0.59; 95% CI, 0.39-0.88; P = .01) and better clinical outcomes (International Knee Documentation Committee [IKDC] score: mean difference [MD], 2.31; 95% CI, 0.54-4.09; P = .01; and Lysholm score: MD, 2.71; 95% CI, 0.68-4.75; P = .009) in the LEAT than non-LEAT group. Graft rerupture rate was 3 times less likely (RR, 0.31; 95% CI, 0.17-0.58; P < .001) in the LEAT group than the non-LEAT group. CONCLUSION: Good-quality evidence is available to support the efficacy of LEAT in improving anterolateral knee stability and reducing graft reruptures in primary ACLR. LEAT should be considered in patients with high risk factors. Although Lysholm and IKDC scores were statistically better in the LEAT group, these are unlikely to be clinically significant. Future studies should aim to identify patient populations that would best benefit from LEAT with ACLR.
引用
- Onggo JR, Rasaratnam HK, Nambiar M, et al. Anterior Cruciate Ligament Reconstruction Alone Versus With Lateral Extra-articular Tenodesis With Minimum 2-Year Follow-up: A Meta-analysis and Systematic Review of Randomized Controlled Trials. Am J Sports Med. 2021. PMID: 33886399. doi:10.1177/03635465211004946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。